81243

Gene analysis (fragile x mental retardation) abnormal alleles

Medicare pricing data for 50 providers across 9 states

🤖AI Overview

Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.

💡 What You Should Know

Gene analysis (fragile x mental retardation) abnormal alleles (HCPCS code 81243) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $55.85, but hospitals typically charge $67.45 — a 1.2x markup. Prices vary significantly by state and provider.

🏷️ Typical Out-of-Pocket Cost

$11.17

Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $55.85, your out-of-pocket cost would be approximately $11.17. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.

Average Allowed Cost
$55.85
Average Hospital Charge
$67.45
Markup Ratio
1.2x

What Hospitals Charge vs. What Medicare Pays

Hospital Charge$67.45
Medicare Allowed$55.85
Medicare Payment$55.85

Hospitals charge 1.2x more than what Medicare allows for this procedure. Medicare actually pays $55.85 on average.

Cost by State

Medicare-allowed amounts vary significantly by state

StateAllowed CostHospital ChargeProvidersServicesvs. National
Louisiana$56$60115+0.1%
Oklahoma$56$873245+0.1%
Pennsylvania$56$5731,103+0.1%
Arizona$56$75160+0.1%
Texas$56$60166,165+0.1%
New Jersey$56$7173,0760.0%
Florida$56$7112854-0.2%
Maryland$54$491383-3.0%
Colorado$52$219317-7.8%

⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.

Related from TheDataProject.ai

💊 Need post-procedure medications? Check costs on OpenPrescriber